Last updated: 2026-09-21 05:37:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Apnimed, Inc. (APMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $28.97, with a market capitalization of $1.21B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.12 to $35.29. This page covers its latest market performance, valuation, price trends and company information.
$1.21B | |
$28.34 | |
$35.29 | |
$16.12 | |
$28.11 | |
471.70K | |
531.48K | |
-- | |
$35.29 | |
$16.12 | |
-- | |
-- |
Apnimed, Inc. (APMD) last closed at $28.11 as of 2026-09-18 23:37:00, unchanged from the previous close of $28.11.
During the latest regular trading session, APMD traded between $16.12 and $35.29, with a volume of 471.70K shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, Apnimed, Inc. (APMD) moved from $26.80 to $28.97, representing a gain of 8.11% ($2.17).
The stock traded between $25.05 and $30.22 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 726.46 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 67.1%
APMD is currently trading at $28.97, placing it 67.1% of the way from its 52-week low of $16.12 to its 52-week high of $35.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Apnimed, Inc. (APMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.